Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Erbach

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Diabetes Science and Technology|May 31, 2014
Impact of a reduced error range of SMBG in insulin-treated patients in GermanyOliver Schnell, Michael Erbach
Journal of Diabetes and Its Complications|February 11, 2012
Diabetes and the risk for colorectal cancerMichael Erbach, Hellmut Mehnert, Oliver Schnell
Cardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver Schnell
Diabetes & Vascular Disease Research|April 18, 2012
Primary and secondary prevention of cardiovascular disease in diabetes with aspirinOliver Schnell, Michael Erbach, Michael Hummel
Diabetes/Metabolism Research and Reviews|January 3, 2013
What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and ConsEberhard Standl, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|August 6, 2013
Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspectsOliver Schnell, Michael Erbach, Eva Wintergerst
Current Treatment Options in Cardiovascular Medicine|October 7, 2014
Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect?Eberhard Standl, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|June 28, 2017
A New Optimized Percutaneous Access System for CIPIIRosa Garcia-Verdugo, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|October 7, 2016
Need for Outcome Scenario Analysis of Clinical Trials in DiabetesRosa Garcia-Verdugo, Michael Erbach, Oliver Schnell
Cardiovascular Diabetology|April 19, 2014
On the potential of acarbose to reduce cardiovascular diseaseEberhard Standl, Michael J Theodorakis, Michael Erbach, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Diabetes Science and Technology|May 31, 2014
Impact of a reduced error range of SMBG in insulin-treated patients in GermanyOliver Schnell, Michael Erbach
Journal of Diabetes and Its Complications|February 11, 2012
Diabetes and the risk for colorectal cancerMichael Erbach, Hellmut Mehnert, Oliver Schnell
Cardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver Schnell
Diabetes & Vascular Disease Research|April 18, 2012
Primary and secondary prevention of cardiovascular disease in diabetes with aspirinOliver Schnell, Michael Erbach, Michael Hummel
Diabetes/Metabolism Research and Reviews|January 3, 2013
What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and ConsEberhard Standl, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|August 6, 2013
Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspectsOliver Schnell, Michael Erbach, Eva Wintergerst
Current Treatment Options in Cardiovascular Medicine|October 7, 2014
Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect?Eberhard Standl, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|June 28, 2017
A New Optimized Percutaneous Access System for CIPIIRosa Garcia-Verdugo, Michael Erbach, Oliver Schnell
Journal of Diabetes Science and Technology|October 7, 2016
Need for Outcome Scenario Analysis of Clinical Trials in DiabetesRosa Garcia-Verdugo, Michael Erbach, Oliver Schnell
Cardiovascular Diabetology|April 19, 2014
On the potential of acarbose to reduce cardiovascular diseaseEberhard Standl, Michael J Theodorakis, Michael Erbach, et al.
Pageof 2